(Q48717671)

English

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group

scientific article published in July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

phase III clinical trial

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

12

object named as

C Blomqvist

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

4

object named as

A Pluzanska

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

author name string

L Hakamies-Blomqvist

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

M Luoma

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

J Sjöström

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

M Sjödin

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

H Mouridsen

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

B Ostenstad

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

I Mjaaland

8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

S Ottosson-Lönn

9

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

J Bergh

10

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

P Malmström

11

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

publication date

1 July 2000

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

36

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

11

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

1411-1417

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

Do patients with advanced breast cancer benefit from chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of recent trials of chemotherapy for advanced breast cancer: studies excluding taxanes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life as an endpoint in EORTC clinical trials. European Organization for Research and Treatment for Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life assessment in clinical trials--guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience. MRC Cancer Trials Office.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life evaluation by the EORTC questionnaire technique in patients with generalized malignant melanoma on chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Missing quality of life data in cancer clinical trials: serious problems and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900126-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(00)00126-X

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/10899655

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48717671&oldid=2207635440"